Deproteinized Natural Rubber Latex as Matrix Base of Meloxicam Transdermal Patches

Jirapornchai Suksaeree; Rungtiwa Waiprib; Weeraya Simchareon; Thawatchai Phaechamud; Wiwat Pichayakorn

doi:10.4028/p-591atj

Paper Titles

Deproteinized Natural Rubber Latex as Matrix Base of Meloxicam Transdermal Patches
p.3

Development of In Situ Cooling Natural Rubber Film
p.9

Impact of Polymers as Precipitation Inhibitors on Physicochemical Properties of Spray-Dried Astaxanthin-Loaded Self-Microemulsifying Delivery Systems
p.15

Cold-Pressed Coconut Oil Cream: Preparation and Evaluation
p.23

Anticancer Activity of Nanoemulsions Loading Biomaterial Amomum kravanh Oil against Oral Cancer Cells
p.31

Antioxidant Activity, Antimicrobial Activities, and Effect on the Viability of Fibroblast Cells of Boesenbergia rotunda- Loaded Hydrogel Patches
p.37

Development of Floating 3D-Printed Devices for Carvedilol Tablet
p.45

Assessment of Shellac as Alternative Material for Preparation of Fused Deposition Modeling (FDM) 3D Printing Filaments
p.53

HomeKey Engineering MaterialsKey Engineering Materials Vol. 914Deproteinized Natural Rubber Latex as Matrix Base...

Deproteinized Natural Rubber Latex as Matrix Base of Meloxicam Transdermal Patches

Abstract:

This study aims to formulate and evaluate the meloxicam (MX) transdermal patches using deproteinized natural rubber latex (DNRL) as a polymer matrix due to its good film forming characteristics. Hydrophobic drug, MX was firstly dissolved in hydroalcoholic solution and incorporated into DNRL with various concentrations of the drug (1-5%w/w). These mixtures were then cast on the glass plate prior to drying and thereafter obtaining the MX-loaded transdermal patches. Increasing amounts of the drug provided more opaque films with more precipitation of drug in films. The highest amount of MX was 3%w/w to incorporate with DNRL to obtain the acceptable patch without any visible precipitation. Compatibility of each ingredient in the formulation was confirmed using differential scanning calorimeter and X-ray diffractometer. The in vitro drug release study showed the increment of MX release from 7.88±0.43% to 13.33±0.87% in receptor medium of modified Franz diffusion cell when the drug concentration in the patches was increased from 1 to 3%w/w. The in vitro drug permeation study also found that MX could penetrate from DNRL transdermal patch through the porcine skin. However, these release and permeation amounts of MX were rather low that should be improved with some specific techniques and should be further investigated.

You might also be interested in these eBooks

Engineering and Industrial Technology: Materials Science

View Preview

Info:

Periodical:

Key Engineering Materials (Volume 914)

Pages:

3-8

DOI:

https://doi.org/10.4028/p-591atj

Citation:

Cite this paper

Online since:

March 2022

Authors:

Jirapornchai Suksaeree, Rungtiwa Waiprib, Weeraya Simchareon, Thawatchai Phaechamud, Wiwat Pichayakorn*

Keywords:

Matrix, Meloxicam, Natural Rubber, Transdermal Patch

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

Citation:

* - Corresponding Author

References

[1] Y.-C. Ah, J.-K. Choi, Y.-K. Choi, H.-M. Ki, J.-H. Bae, A novel transdermal patch incorporating meloxicam: In vitro and in vivo characterization, Int. J. Pharm. 385 (2010) 12-19.